<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Techniques for transcatheter aortic valve implantation involve manipulation of the native aortic valve and the aortic arch </plain></SENT>
<SENT sid="1" pm="."><plain>As a result, excellent technical outcomes of this technique remain counterbalanced by a level of neurologic complications that remain unacceptably high </plain></SENT>
<SENT sid="2" pm="."><plain>We present here a report of a new potential combined approach to reduce periprocedural neurologic events </plain></SENT>
<SENT sid="3" pm="."><plain>After a 6-cm J-shaped upper-mini-sternotomy, 26-mm Sapien valve (<z:e sem="disease" ids="C0152096" disease_type="Disease or Syndrome" abbrv="">Edwards</z:e> Lifesciences, Irvine, CA) was deployed through a transaortic approach </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, the Embol-X device (<z:e sem="disease" ids="C0152096" disease_type="Disease or Syndrome" abbrv="">Edwards</z:e> Lifescience) was directly inserted in the distal ascending aorta was deployed during <z:hpo ids='HP_0000001'>all</z:hpo> the procedure </plain></SENT>
<SENT sid="5" pm="."><plain>Postoperative evolution was clinically uneventful </plain></SENT>
<SENT sid="6" pm="."><plain>Postoperative magnetic resonance imaging revealed no new ischemic lesions in this first patient </plain></SENT>
</text></document>